Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/124220
dc.contributor.author | Llorens Torres, Franc |
---|---|
dc.contributor.author | Thune, Katrin |
dc.contributor.author | Tahir, Waqas |
dc.contributor.author | Kanata, Eirini |
dc.contributor.author | Diaz-Lucena, Daniela |
dc.contributor.author | Xanthopoulos, Konstantinos |
dc.contributor.author | Kovatsi, Eleni |
dc.contributor.author | Pleschka, Catharina |
dc.contributor.author | Garcia Esparcia, Paula |
dc.contributor.author | Schmitz, Matthias |
dc.contributor.author | Ozbay, Duru |
dc.contributor.author | Correia, Susana |
dc.contributor.author | Correia, Ângela |
dc.contributor.author | Milosevic, Ira |
dc.contributor.author | Andreoletti, Olivier |
dc.contributor.author | Fernández Borges, Natalia |
dc.contributor.author | Vorberg, Ina M. |
dc.contributor.author | Glatzel, Markus |
dc.contributor.author | Sklaviadis, Theodoros |
dc.contributor.author | Torres, Juan Maria |
dc.contributor.author | Krasemann, Susanne |
dc.contributor.author | Sánchez del Valle Díaz, Raquel |
dc.contributor.author | Ferrer, Isidro (Ferrer Abizanda) |
dc.contributor.author | Zerr, Inga |
dc.date | 2018-09-03T13:17:32Z |
dc.date | 2018-09-03T13:17:32Z |
dc.date | 2017-11-10 |
dc.date | 2018-07-24T11:55:57Z |
dc.identifier | 29126445 |
dc.identifier.uri | http://hdl.handle.net/2445/124220 |
dc.description | Background: YKL-40 (also known as Chitinase 3-like 1) is a glycoprotein produced by inflammatory, cancer and stem cells. Its physiological role is not completely understood but YKL-40 is elevated in the brain and cerebrospinal fluid (CSF) in several neurological and neurodegenerative diseases associated with inflammatory processes. Yet the precise characterization of YKL-40 in dementia cases is missing. Methods: In the present study, we comparatively analysed YKL-40 levels in the brain and CSF samples from neurodegenerative dementias of different aetiologies characterized by the presence of cortical pathology and disease-specific neuroinflammatory signatures. Results: YKL-40 was normally expressed in fibrillar astrocytes in the white matter. Additionally YKL-40 was highly and widely expressed in reactive protoplasmic cortical and perivascular astrocytes, and fibrillar astrocytes in sporadic Creutzfeldt-Jakob disease (sCJD). Elevated YKL-40 levels were also detected in Alzheimer's disease (AD) but not in dementia with Lewy bodies (DLB). In AD, YKL-40-positive astrocytes were commonly found in clusters, often around beta-amyloid plaques, and surrounding vessels with beta-amyloid angiopathy; they were also distributed randomly in the cerebral cortex and white matter. YKL-40 overexpression appeared as a pre-clinical event as demonstrated in experimental models of prion diseases and AD pathology. CSF YKL-40 levels were measured in a cohort of 288 individuals, including neurological controls (NC) and patients diagnosed with different types of dementia. Compared to NC, increased YKL-40 levels were detected in sCJD (p < 0.001, AUC = 0.92) and AD (p < 0.001, AUC = 0.77) but not in vascular dementia (VaD) (p > 0.05, AUC = 0.71) or in DLB/Parkinson's disease dementia (PDD) (p > 0.05, AUC = 0.70). Further, two independent patient cohorts were used to validate the increased CSF YKL-40 levels in sCJD. Additionally, increased YKL-40 levels were found in genetic prion diseases associated with the PRNP-D178N (Fatal Familial Insomnia) and PRNP-E200K mutations. Conclusions: Our results unequivocally demonstrate that in neurodegenerative dementias, YKL-40 is a disease-specific marker of neuroinflammation showing its highest levels in prion diseases. Therefore, YKL-40 quantification might have a potential for application in the evaluation of therapeutic intervention in dementias with a neuroinflammatory component. |
dc.format | 21 p. |
dc.format | application/pdf |
dc.language | eng |
dc.publisher | BioMed Central |
dc.relation | Reproducció del document publicat a: http://dx.doi.org/10.1186/s13024-017-0226-4 |
dc.relation | Molecular Neurodegeneration, 2017, vol. 12, num. 83 |
dc.relation | http://dx.doi.org/10.1186/s13024-017-0226-4 |
dc.rights | cc by (c) Llorens et al., 2017 |
dc.rights | http://creativecommons.org/licenses/by/3.0/es/ |
dc.rights | info:eu-repo/semantics/openAccess |
dc.subject | Malalties neurodegeneratives |
dc.subject | Glicoproteïnes |
dc.subject | Neurodegenerative diseases |
dc.subject | Glycoproteins |
dc.title | Ykl-40 in the brain and cerebrospinal fluid of neurodegenerative dementias |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |